Gene · 1195
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multimodal CMOS Readout IC for SWIR Image Sensors with Dual-Mode BDI/DI Pixels and Column-Parallel Two-Step Single-Slope ADC. | Micromachines (Basel) | 2025 | 40731681 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| Advances in Drug Discovery for Cardiomyocyte Proliferation. | Curr Treat Options Cardiovasc Med | 2025 | 40693046 | PubTator, text mining | PubMed |
| A novel obfuscation method based on majority logic for preventing unauthorized access to binary deep neural networks. | Sci Rep | 2025 | 40628915 | PubTator, text mining | PubMed |
| Stable H-bond networks are crucial for selective CLK1 inhibition: a computational perspective. | Front Chem | 2025 | 40599151 | PubTator, text mining | PubMed |
| Molecular dynamics simulations of intrinsically disordered protein regions enable biophysical interpretation of variant effect predictors. | bioRxiv | 2025 | 40462930 | PubTator, text mining | PubMed |
| The Design of a Computer Vision Sensor Based on a Low-Power Edge Detection Circuit. | Sensors (Basel) | 2025 | 40432010 | PubTator, text mining | PubMed |
| YTHDC1 orchestrates oncogenic splicing via the CLK1-SRSF1 splicing machinery to regulate castration-resistant prostate cancer progression. | Mol Cell Biochem | 2025 | 40404917 | PubTator, text mining | PubMed |
| Benchmarking of methods that identify alternative polyadenylation events in single-/multiple-polyadenylation site genes. | NAR Genom Bioinform | 2025 | 40371010 | PubTator, text mining | PubMed |
| Trifunctional antibody-cytokine fusion protein formats for tumor-targeted combination of IL-15 with IL-7 or IL-21. | Front Immunol | 2025 | 40370435 | PubTator, text mining | PubMed |
| Designing a time-to-digital converter using quantum-dot cellular automata nanotechnology. | Sci Rep | 2025 | 40325113 | PubTator, text mining | PubMed |
| UAV Onboard STAR-RIS Service Enhancement Mechanism Based on Deep Reinforcement Learning. | Sensors (Basel) | 2025 | 40293096 | PubTator, text mining | PubMed |
| Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets. | Chem Res Toxicol | 2025 | 40253625 | PubTator, text mining | PubMed |
| Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1. | Sci Rep | 2025 | 40253440 | PubTator, text mining | PubMed |
| The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle. | PLoS Pathog | 2025 | 40203066 | PubTator, text mining | PubMed |
| Benzamide Derivatives of Thioacridine as DYRK2 and DYRK3 Dual Inhibitors. | ChemMedChem | 2025 | 40145237 | PubTator, text mining | PubMed |
| Molecular Dynamics Study on the Influence of the CLK Motif on the Structural Stability of Collagen-Like Peptides Adsorbed on Gold Nanosurfaces. | ACS Omega | 2025 | 40124015 | PubTator, text mining | PubMed |
| Structural design of memory system for Ternary Optical Computer. | PLoS One | 2025 | 40019869 | PubTator, text mining | PubMed |
| Selection of Early Life Codons by Ultraviolet Light. | ACS Cent Sci | 2025 | 39866696 | PubTator, text mining | PubMed |
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. | Clin Exp Rheumatol | 2025 | 39808288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1195/papers?page=4